PremiumRatingsATAI Life Sciences: Promising Clinical Data and Strategic Investments Drive Buy Rating Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies Home Depot backs outlook as U.S. sales ticked up: Morning Buzz PremiumRatingsATAI Life Sciences: Strong Financial Position and Promising Pipeline Drive Buy Rating VA secretary wants to find answers on psychedelics therapies, Politico says Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results PremiumCompany AnnouncementsATAI Life Sciences Repays Hercules Loan Early ATAI Life Sciences Finalizes Separation with CBO Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial 
